These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18161128)

  • 1. [Evidence of risedronate for treatment of osteoporosis].
    Soen S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():344-7. PubMed ID: 18161128
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evidence of alendronate treatment for osteoporosis].
    Harada A
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():337-43. PubMed ID: 18161127
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evidence and utility of etidronate for the treatment of osteoporosis].
    Takada J; Iba K; Yamashita T; Yoshizaki T
    Clin Calcium; 2008 Oct; 18(10):1427-33. PubMed ID: 18830039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risedronate treatment for osteoporosis].
    Kishimoto H
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():419-22. PubMed ID: 15035163
    [No Abstract]   [Full Text] [Related]  

  • 5. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
    Soen S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():325-8. PubMed ID: 18159713
    [No Abstract]   [Full Text] [Related]  

  • 6. [Risedronate: clinical usage].
    Shiraki M
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():529-37. PubMed ID: 11979951
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evidence for efficacy of active vitamin D3 as an anti-osteoporotic drug].
    Inoue D
    Clin Calcium; 2008 Oct; 18(10):1469-75. PubMed ID: 18830044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in the treatment of osteoporosis].
    Sugimoto T
    Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of fractures with therapeutic agents for osteoporosis].
    Hosoi T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():596-601. PubMed ID: 15035197
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.
    Fukunaga M; Kushida K; Kishimoto H; Shiraki M; Taketani Y; Minaguchi H; Inoue T; Morita R; Morii H; Yamamoto K; Ohashi Y; Orimo H;
    Osteoporos Int; 2002 Dec; 13(12):971-9. PubMed ID: 12459940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and tolerability of once-weekly administration of 35 mg alendronate and 17.5 mg risedronate].
    Kishimoto H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():365-8. PubMed ID: 18161133
    [No Abstract]   [Full Text] [Related]  

  • 12. [VERT(Vertebral Efficacy with Risedronate Therapy)-MN(Multinational) Study and VERT-NA(North America) Study].
    Fukunaga M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():433-6. PubMed ID: 15035166
    [No Abstract]   [Full Text] [Related]  

  • 13. Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures.
    Ohtori S; Akazawa T; Murata Y; Kinoshita T; Yamashita M; Nakagawa K; Inoue G; Nakamura J; Orita S; Ochiai N; Kishida S; Takaso M; Eguchi Y; Yamauchi K; Suzuki M; Aoki Y; Takahashi K
    J Clin Neurosci; 2010 Feb; 17(2):209-13. PubMed ID: 20044258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Men also need bone protection].
    MMW Fortschr Med; 2006 Nov; 148(46):48-9. PubMed ID: 17615790
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bone quality in treatment with raroxifene ].
    Nakamura T
    Clin Calcium; 2004 May; 14(5):813-8. PubMed ID: 15577047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EBM of calcitonin].
    Mori S
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():242-5. PubMed ID: 16279640
    [No Abstract]   [Full Text] [Related]  

  • 17. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study.
    Boonen S; Orwoll ES; Wenderoth D; Stoner KJ; Eusebio R; Delmas PD
    J Bone Miner Res; 2009 Apr; 24(4):719-25. PubMed ID: 19049326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bisphosphonates: pharmacology and use in the treatment of osteoporosis].
    Kishimoto H
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():350-8. PubMed ID: 11979929
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evidence in the treatment of osteoporosis using weekly teriparatide injections].
    Nakamura Y
    Clin Calcium; 2012 Mar; 22(3):407-13. PubMed ID: 22370308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.